Natural Alternatives International, Inc. (NAII)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 179 | 171 | 154 | 114 | 130 | - | 141 | - |
| Operating profit | $m | -9 | -8 | ||||||
| Net profit | $m | 11 | 11 | 3 | -7 | -14 | - | -14 | - |
| EPS reported | $ | -2.28 | -2.36 | ||||||
| Operating cashflow per share | $ | 1.00 | -0.75 | ||||||
| Capex per share | $ | 0.61 | 0.75 | ||||||
| FCF per share | $ | 0.39 | -1.50 | ||||||
| Free cash flow | $m | 2 | -9 | ||||||
| Net debt | $m | -1 | 10 | ||||||
| Book value equity | $m | 68 | 63 | ||||||
| Book value per share | $ | 11.51 | 10.47 | ||||||
| Number of shares | m | 5.95 | 6.03 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.49 | 0.31 | ||||||
| P/S LTM | x | 0.26 | 0.14 | ||||||
| P/FCF LTM | x | 14.43 | -2.16 | ||||||
| EV/EBITDA LTM | x | -30.28 | -34.79 | ||||||
| EV/Sales LTM | x | 0.51 | 0.49 | ||||||
| Earnings Yield LTM | % | -69.59% | -1.17% | ||||||
| FCF Yield | % | +6.93% | -46.26% | ||||||
| Quality | |||||||||
| ROE | % | -19.84% | -21.48% | ||||||
| ROIC | % | -6.79% | -6.31% | ||||||
| Operating margin | % | -6.67% | -5.74% | ||||||
| Gross margin | % | +7.15% | +7.04% | ||||||
| FCF/Sales | % | +1.78% | -6.40% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +14.12% | +8.57% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.04 | -0.14 | ||||||
| Net Debt/EBITDA | x | -17.30 | -29.41 | ||||||
| EBIT/Net interest | x | -9.46 | -8.69 | ||||||
| Net debt/market cap | % | +55.54% | +1.46% | ||||||
| Net debt/Equity | x | -0.02 | 0.15 | ||||||
| Gross debt/equity | x | 0.86 | 1.03 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Natural Alternatives International, Inc. (NAII)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free